Literature DB >> 27275492

Revisiting of cancer vaccine?-Specific immunotherapy comes to field with the biomarker.

Yuki Owada1, Satoshi Muto1, Takeo Hasegawa1, Mitsunori Higuchi1, Hiroyuki Suzuki1.   

Abstract

Entities:  

Year:  2016        PMID： 27275492      PMCID： PMC4876275          DOI： 10.21037/atm.2016.04.17

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  17 in total

1.  Effect of prior splenectomy on the growth of sarcoma 180 in normal and Bacillus Calmette-Guerin infected mice.

Authors:  L J OLD; D A CLARKE; B BENACERRAF; E STOCKERT
Journal:  Experientia       Date:  1962-07-15

2.  Improved survival with ipilimumab in patients with metastatic melanoma.

Authors:  F Stephen Hodi; Steven J O'Day; David F McDermott; Robert W Weber; Jeffrey A Sosman; John B Haanen; Rene Gonzalez; Caroline Robert; Dirk Schadendorf; Jessica C Hassel; Wallace Akerley; Alfons J M van den Eertwegh; Jose Lutzky; Paul Lorigan; Julia M Vaubel; Gerald P Linette; David Hogg; Christian H Ottensmeier; Celeste Lebbé; Christian Peschel; Ian Quirt; Joseph I Clark; Jedd D Wolchok; Jeffrey S Weber; Jason Tian; Michael J Yellin; Geoffrey M Nichol; Axel Hoos; Walter J Urba
Journal:  N Engl J Med       Date:  2010-06-05       Impact factor: 91.245

Review 3.  Combinatorial Cancer Immunotherapies.

Authors:  Matthew D Hellmann; Claire F Friedman; Jedd D Wolchok
Journal:  Adv Immunol       Date:  2016-01-12       Impact factor: 3.543

Review 4.  Vaccination therapy for non-small-cell lung cancer.

Authors:  Kristof Cuppens; Johan Vansteenkiste
Journal:  Curr Opin Oncol       Date:  2014-03       Impact factor: 3.645

5.  Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer.

Authors:  John Nemunaitis; Robert O Dillman; Paul O Schwarzenberger; Neil Senzer; Casey Cunningham; Jodi Cutler; Alex Tong; Padmasini Kumar; Beena Pappen; Cody Hamilton; Edward DeVol; Phillip B Maples; Lily Liu; Terry Chamberlin; Daniel L Shawler; Habib Fakhrai
Journal:  J Clin Oncol       Date:  2006-09-11       Impact factor: 44.544

6.  A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

Authors:  P van der Bruggen; C Traversari; P Chomez; C Lurquin; E De Plaen; B Van den Eynde; A Knuth; T Boon
Journal:  Science       Date:  1991-12-13       Impact factor: 47.728

7.  Cancer immunotherapy: moving beyond current vaccines.

Authors:  Steven A Rosenberg; James C Yang; Nicholas P Restifo
Journal:  Nat Med       Date:  2004-09       Impact factor: 53.440

8.  Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Authors:  Hossein Borghaei; Luis Paz-Ares; Leora Horn; David R Spigel; Martin Steins; Neal E Ready; Laura Q Chow; Everett E Vokes; Enriqueta Felip; Esther Holgado; Fabrice Barlesi; Martin Kohlhäufl; Oscar Arrieta; Marco Angelo Burgio; Jérôme Fayette; Hervé Lena; Elena Poddubskaya; David E Gerber; Scott N Gettinger; Charles M Rudin; Naiyer Rizvi; Lucio Crinò; George R Blumenschein; Scott J Antonia; Cécile Dorange; Christopher T Harbison; Friedrich Graf Finckenstein; Julie R Brahmer
Journal:  N Engl J Med       Date:  2015-09-27       Impact factor: 91.245

9.  Enhancement of antitumor immunity by CTLA-4 blockade.

Authors:  D R Leach; M F Krummel; J P Allison
Journal:  Science       Date:  1996-03-22       Impact factor: 47.728

Review 10.  Pointed Progress in Second-Line Advanced Non-Small-Cell Lung Cancer: The Rapidly Evolving Field of Checkpoint Inhibition.

Authors:  Barbara Melosky; Quincy Chu; Rosalyn Juergens; Natasha Leighl; Deanna McLeod; Vera Hirsh
Journal:  J Clin Oncol       Date:  2016-02-16       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.